Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H (SFOSF)
OTHER OTC:SFOSF
Holding SFOSF?
Track your performance easily
SFOSF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.23 - $2.24
Previous CloseN/A
Volume200.00
Average Volume (3M)105.00
Market Cap
$7.73B
Enterprise ValueN/A
Total Cash (Recent Filing)$6.04B
Total Debt (Recent Filing)$6.28B
Price to Earnings (P/E)14.7
Beta0.86
Next Earnings
Mar 31, 2025EPS Estimate
0.04Last Dividend Ex-Date
Jul 26, 2024Dividend Yield2.37%
Share Statistics
EPS (TTM)0.11
Shares Outstanding551,940,500
10 Day Avg. Volume0
30 Day Avg. Volume105
Standard Deviation0.15
R-Squared0.05
Alpha-0.00505
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.19
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$1.82Price Target Upside12.35% Upside
Rating ConsensusHold
Number of Analyst Covering1
Shanghai Fosun Pharmaceutical (Group) Co News
PremiumCompany Announcements
Shanghai Fosun Pharmaceutical Approves 2025 Share Repurchase Plans
PremiumCompany Announcements
Fosun Pharma’s Privatization Proposal for Henlius Falls Through
PremiumCompany Announcements
Fosun Pharma Subsidiary Gains Approval for New Drug
PremiumCompany Announcements
Fosun Pharma’s Subsidiary Gains Approval for Oxazepam Tablets
PremiumCompany Announcements
Fosun Pharma Subsidiary Advances Drug for Glomerular DiseasesPremiumCompany Announcements
Fosun Pharma’s Subsidiary Advances Breast Cancer Drug RegistrationPremiumCompany Announcements
Shanghai Fosun Pharma’s New Cancer Drug Application Accepted
PremiumCompany Announcements
Shanghai Fosun Pharmaceutical Advances Henlius Merger PlansOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
3.62% Mutual Funds
― Other Institutional Investors
94.25% Public Companies and
Individual Investors
SFOSF FAQ
What was Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s price range in the past 12 months?
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H lowest stock price was $1.23 and its highest was $2.24 in the past 12 months.
What is Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s market cap?
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s market cap is $7.73B.
When is Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s upcoming earnings report date?
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s upcoming earnings report date is Mar 31, 2025 which is in 67 days.
How were Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s earnings last quarter?
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H released its earnings results on Oct 30, 2024. The company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.04 by >-$0.001.
Is Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H overvalued?
According to Wall Street analysts Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s price is currently Undervalued.
Does Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H pay dividends?
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H pays a Annually dividend of $0.039 which represents an annual dividend yield of 2.37%. See more information on Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H dividends here
What is Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s EPS estimate?
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s EPS estimate is 0.04.
How many shares outstanding does Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H have?
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H has 551,940,500 shares outstanding.
What happened to Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H’s price movement after its last earnings report?
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H reported an EPS of $0.04 in its last earnings report, missing expectations of $0.04. Following the earnings report the stock price went up 1.053%.
Which hedge fund is a major shareholder of Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H?
Currently, no hedge funds are holding shares in SFOSF
---
Shanghai Fosun Pharmaceutical (Group) Co Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$1.82 (12.35% Upside)
$1.82 (12.35% Upside)
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-16.14%
12-Months-Change
Fundamentals
Return on Equity
4.51%
Trailing 12-Months
Asset Growth
8.33%
Trailing 12-Months
Company Description
Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H
Shanghai Fosun Pharmaceutical Group Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products and medical equipment, import and export of medical equipment, healthcare services, and the provision of related and other consulting services and investment management. It operates through the following business segment: Pharmaceutical Manufacturing and R&D; Healthcare Service; Medical Devices and Medical Diagnosis; Pharmaceutical Distribution and Retail; and Other Business Operations. The Pharmaceutical Manufacturing and R&D segment involves in the production, sale, and research of medicine. The Healthcare Service segment provides healthcare service and hospital management. The Medical Devices and Medical Diagnosis segment focuses on the production and sale of medical equipment and diagnostic products. The Pharmaceutical Distribution and Retail segment issue retail and wholesale of medicine. The Other Business Operations segment comprises business that is different from the role of other segments. The company was founded on January 14, 1994 and is headquartered in Shanghai, China.
---
Technical Analysis
---